Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease modification in partial epilepsy.

M C Walker1, H S White, J W A S Sander

  • 1Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London WC1N 3BG, UK.

Brain : a Journal of Neurology
|August 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
Same author

CARTR Plus: the creation of an ART registry in Canada.

Human reproduction open·2020
Same author

Reactive oxygen species in status epilepticus.

Epilepsy & behavior : E&B·2019
Same author

Nanoscale electrochemical kinetics & dynamics: the challenges and opportunities of single-entity measurements.

Faraday discussions·2018
Same author

Decreasing the risk of sudden unexpected death in epilepsy: structured communication of risk factors for premature mortality in people with epilepsy.

European journal of neurology·2018
Same author

A case of pure gelastic seizures due to hypothalamic hamartoma with a benign course.

Epilepsy & behavior case reports·2017
Same journal

Disrupted WWOX-MYC interplay impairs neurogenesis in human brain organoids.

Brain : a journal of neurology·2026
Same journal

SMPD4 deficiency disrupts indirect neurogenesis and neuronal migration in gyrencephalic cortex.

Brain : a journal of neurology·2026
Same journal

Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.

Brain : a journal of neurology·2026
Same journal

Two scripts, two pathways: dorsal-ventral biases in post-stroke kana-kanji agraphia.

Brain : a journal of neurology·2026
Same journal

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same journal

Time to reconsider risk for psychosis?

Brain : a journal of neurology·2026
See all related articles

Current antiepileptic drugs treat seizures, not the underlying cause of epilepsy (epileptogenesis). Research explores preventing epilepsy development after initial insults, offering hope for future targeted therapies.

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Pharmacology

Background:

  • Epileptogenesis is the process of developing epilepsy after an initial insult, involving structural and functional brain changes.
  • Animal models like kindling and those involving insults (status epilepticus, trauma) help study epileptogenesis.
  • The "second hit" hypothesis suggests an initial insult lowers seizure threshold, with a later event triggering epilepsy.

Purpose of the Study:

  • To review the concepts and model systems underlying epileptogenesis.
  • To explore the potential for interrupting epileptogenesis with targeted therapies.
  • To evaluate the effectiveness of current antiepileptic drugs in preventing epileptogenesis.

Main Methods:

  • Review of existing literature on epileptogenesis and animal models.

Related Experiment Videos

  • Analysis of data from epidemiological studies and clinical trials.
  • Examination of experimental data on the effects of treating non-convulsive status epilepticus.

    • Main Results:

    • Current antiepileptic drugs are not designed to prevent epileptogenesis and are ineffective for this purpose.
    • Animal studies suggest treating non-convulsive status epilepticus post-insult may prevent epileptogenesis.
    • Improved neonatal care has led to decreased childhood epilepsy, emphasizing prevention at the time of insult.

    Conclusions:

    • Targeting epileptogenesis, rather than just seizures, is crucial for epilepsy treatment.
    • Preventing the epileptogenic process, potentially during a latent period, is a promising therapeutic strategy.
    • Further research is needed to validate human correlates of animal models and develop effective anti-epileptogenic therapies.